Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$7.4MFederal grants as PI9 awards
2Patents grantedLatest Aug 31, 2021
93Papers9,048 citations
Federal awards and patents by year
AwardsPatents
9 awards · $7.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 24, 2020 | NIH | SBIR Phase II PDE4D PET Ligand | $625K | TETRA DISCOVERY PARTNERS LLC |
| Jan 24, 2020 | NIH | SBIR Phase II PDE4D PET Ligand | $625K | Tetra Discovery Partners, Inc. |
| Sep 10, 2018 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Alzheimer's Disease | $412K | TETRA DISCOVERY PARTNERS LLC |
| Sep 10, 2018 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Alzheimer's Disease | $412K | Tetra Discovery Partners, Inc. |
| Aug 6, 2018 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease | $982K | TETRA DISCOVERY PARTNERS LLC |
| Aug 6, 2018 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease | $982K | Tetra Discovery Partners, Inc. |
| Aug 14, 2017 | NIH | SBIR Phase II BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects | $109K | TETRA DISCOVERY PARTNERS LLC |
| Aug 14, 2017 | NIH | SBIR Phase II BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects | $109K | Tetra Discovery Partners, Inc. |
| Aug 7, 2017 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease | $987K | TETRA DISCOVERY PARTNERS LLC |
| Aug 7, 2017 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease | $987K | Tetra Discovery Partners, Inc. |
| Sep 20, 2016 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease | $991K | TETRA DISCOVERY PARTNERS LLC |
| Sep 20, 2016 | NIH | SBIR Phase II Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease | $991K | Tetra Discovery Partners, Inc. |
| Sep 15, 2016 | NIH | SBIR Phase II BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects | $2.1M | TETRA DISCOVERY PARTNERS LLC |
| Sep 15, 2016 | NIH | SBIR Phase II BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects | $2.1M | Tetra Discovery Partners, Inc. |
| Jul 2, 2015 | NIH | SBIR Phase II PDE4B Inhibitors For Treating Major Depression | $1.0M | TETRA DISCOVERY PARTNERS LLC |
| Jul 2, 2015 | NIH | SBIR Phase II PDE4B Inhibitors For Treating Major Depression | $1.0M | Tetra Discovery Partners, Inc. |
| May 11, 2015 | NIH | STTR Phase I PDE4B Inhibitors for Treating Brain Injury | $225K | TETRA DISCOVERY PARTNERS LLC |
| May 11, 2015 | NIH | STTR Phase I PDE4B Inhibitors for Treating Brain Injury | $225K | Tetra Discovery Partners, Inc. |
3 patents as inventor
- US 11028050TETRA DISCOVERY PARTNERS LLCJun 8, 2021
- US 11104660TETRA DISCOVERY PARTNERS LLCAug 31, 2021
- US TETRA DISCOVERY PARTNERS LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#135
Awards as PI#166
Patents#185
Companies
- Tetra Discovery Partners, Inc.Linked by awards · Medtech
- TETRA DISCOVERY PARTNERS LLCLinked by awards
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.